{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T19:17:06Z","timestamp":1782155826618,"version":"3.54.5"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T00:00:00Z","timestamp":1747526400000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004489","name":"Mitacs Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000034","name":"Institute of Neurosciences Mental Health and Addiction","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000034","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Stress"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ynstr.2025.100732","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T23:56:55Z","timestamp":1747699015000},"page":"100732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?"],"prefix":"10.1016","volume":"36","author":[{"given":"Alanna","family":"Kit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5494-0551","authenticated-orcid":false,"given":"Savannah","family":"Makarowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"O'Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy R.","family":"Shultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara S.","family":"Bodnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6830-0160","authenticated-orcid":false,"given":"Brian R.","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ynstr.2025.100732_bib1","first-page":"1","article-title":"Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential","volume":"2023","author":"Allen","year":"2024","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-019-0308-4","article-title":"Psychedelic microdosing benefits and challenges: an empirical codebook","volume":"16","author":"Anderson","year":"2019","journal-title":"Harm Reduct. J."},{"issue":"2","key":"10.1016\/j.ynstr.2025.100732_bib3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00213-018-5106-2","article-title":"Microdosing psychedelics: personality, mental health, and creativity differences in microdosers","volume":"236","author":"Anderson","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ynstr.2025.100732_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ibror.2018.11.008","article-title":"The human hypothalamus in mood disorders: the HPA axis in the center","volume":"6","author":"Bao","year":"2019","journal-title":"IBRO Rep."},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-05756-0","article-title":"Associations of neurotransmitters and the gut microbiome with emotional distress in mixed type of irritable bowel syndrome","volume":"12","author":"Barandouzi","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ynstr.2025.100732_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.bjp.0705929","article-title":"The 5-HT 4 receptor agonist, tegaserod, is a potent 5-HT 2B receptor antagonist in vitro and in vivo","volume":"143","author":"Beattie","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.ynstr.2025.100732_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41559-017-0141","article-title":"Fungus-like mycelial fossils in 2.4-billion-year-old vesicular basalt","volume":"1","author":"Bengtson","year":"2017","journal-title":"Nat. Ecol. Evol."},{"issue":"Issue FEB","key":"10.1016\/j.ynstr.2025.100732_bib8","article-title":"The vagus nerve at the interface of the microbiota-gut-brain axis","volume":"12","author":"Bonaz","year":"2018","journal-title":"Front. Neurosci."},{"issue":"20","key":"10.1016\/j.ynstr.2025.100732_bib9","first-page":"5781","article-title":"Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation","volume":"594","author":"Bonaz","year":"2016","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.ynstr.2025.100732_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/1178646920928984","article-title":"Tryptophan metabolites along the microbiota-gut-brain Axis: an interkingdom communication system influencing the gut in health and disease","volume":"13","author":"Bosi","year":"2020","journal-title":"Int. J. Tryptophan Res."},{"issue":"38","key":"10.1016\/j.ynstr.2025.100732_bib11","doi-asserted-by":"crossref","first-page":"16050","DOI":"10.1073\/pnas.1102999108","article-title":"Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve","volume":"108","author":"Bravo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"7","key":"10.1016\/j.ynstr.2025.100732_bib12","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/acschemneuro.8b00692","article-title":"Chronic, intermittent microdoses of the psychedelic N, N-Dimethyltryptamine (DMT) produce positive effects on mood and anxiety in rodents","volume":"10","author":"Cameron","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.ynstr.2025.100732_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/02791072.2020.1718250","article-title":"Psychedelic microdosing: prevalence and subjective effects","volume":"52","author":"Cameron","year":"2020","journal-title":"J. Psychoact. Drugs"},{"issue":"8","key":"10.1016\/j.ynstr.2025.100732_bib14","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","article-title":"Leaky gut: mechanisms, measurement and clinical implications in humans","volume":"68","author":"Camilleri","year":"2019","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.ynstr.2025.100732_bib15","first-page":"238","article-title":"From lore to lab: do alterations of consciousness enhance human functioning?","volume":"7","author":"Carde\u00f1a","year":"2020","journal-title":"Psychol. Conscious.: Theory Res. Pract."},{"issue":"7","key":"10.1016\/j.ynstr.2025.100732_bib16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.ynstr.2025.100732_bib17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1192\/bjp.bp.111.103309","article-title":"Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin","volume":"200","author":"Carhart-Harris","year":"2012","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nrl.2011.07.003","article-title":"Hallucinogenic drugs in pre-Columbian Mesoamerican cultures","volume":"30","author":"Carod-Artal","year":"2015","journal-title":"Neurologia"},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-022-02039-0","article-title":"Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study","volume":"12","author":"Cavanna","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ynstr.2025.100732_bib20","series-title":"That Gut Feeling: the Role of Inflammatory Cytokines in Depression Among Patients with Inflammatory Bowel Disease","author":"Chapman","year":"2020"},{"key":"10.1016\/j.ynstr.2025.100732_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-025-08880-9","article-title":"Psychedelic control of neuroimmune interactions governing fear","author":"Chung","year":"2025","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ynstr.2025.100732_bib22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrn3346","article-title":"Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour","volume":"13","author":"Cryan","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ynstr.2025.100732_bib23","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain Axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ynstr.2025.100732_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.yfrne.2018.04.002","article-title":"The neuroendocrinology of the microbiota-gut-brain Axis: a behavioural perspective","volume":"51","author":"Cussotto","year":"2018","journal-title":"Front. Neuroendocrinol."},{"issue":"5","key":"10.1016\/j.ynstr.2025.100732_bib25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ynstr.2025.100732_bib26","article-title":"Psychedelics and neuroplasticity: a systematic review unraveling the biological underpinnings of psychedelics","volume":"vol. 12","author":"de Vos","year":"2021"},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/03602532.2016.1278228","article-title":"Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance","volume":"49","author":"Dinis-Oliveira","year":"2017","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41398-023-02414-5","article-title":"Sex-specific effects of psychedelic drug exposure on central amygdala reactivity and behavioral responding","volume":"13","author":"Effinger","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.ynstr.2025.100732_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/02791072.2019.1593561","article-title":"Might microdosing psychedelics Be safe and beneficial? An initial exploration","volume":"51","author":"Fadiman","year":"2019","journal-title":"J. Psychoact. Drugs"},{"issue":"4","key":"10.1016\/j.ynstr.2025.100732_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/09540261.2018.1481827","article-title":"Psychedelics as anti-inflammatory agents","volume":"30","author":"Flanagan","year":"2018","journal-title":"Int. Rev. Psychiatr."},{"issue":"40","key":"10.1016\/j.ynstr.2025.100732_bib31","doi-asserted-by":"crossref","first-page":"12524","DOI":"10.1002\/ange.201705489","article-title":"Enzymatische Synthese von Psilocybin","volume":"129","author":"Fricke","year":"2017","journal-title":"Angew. Chem."},{"issue":"Issue 6","key":"10.1016\/j.ynstr.2025.100732_bib32","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.neuron.2019.02.008","article-title":"Gut microbe to brain signaling: what happens in vagus\u2026","volume":"101","author":"F\u00fclling","year":"2019","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.ynstr.2025.100732_bib33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/0269881121991822","article-title":"Optimal dosing for psilocybin pharmacotherapy: considering weight-adjusted and fixed dosing approaches","volume":"35","author":"Garcia-Romeu","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ynstr.2025.100732_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2018.00397","article-title":"Breath of life: the respiratory vagal stimulation model of contemplative activity","volume":"12","author":"Gerritsen","year":"2018","journal-title":"Front. Hum. Neurosci."},{"issue":"5","key":"10.1016\/j.ynstr.2025.100732_bib35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tics.2023.01.003","article-title":"A complex systems perspective on psychedelic brain action","volume":"27","author":"Girn","year":"2023","journal-title":"Trends Cognit. Sci."},{"issue":"12","key":"10.1016\/j.ynstr.2025.100732_bib36","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.ynstr.2025.100732_bib37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","article-title":"Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects","volume":"218","author":"Griffiths","year":"2011","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ynstr.2025.100732_bib39","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.2147\/JIR.S384949","article-title":"Vagus nerve and underlying impact on the gut microbiota-brain Axis in behavior and neurodegenerative diseases","volume":"15","author":"Han","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ynstr.2025.100732_bib40","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.2147\/JIR.S384949","article-title":"Vagus nerve and underlying impact on the gut microbiota-brain Axis in behavior and neurodegenerative diseases","volume":"15","author":"Han","year":"2022","journal-title":"J. Inflamm. Res."},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010578","article-title":"Selected biomarkers of depression: what are the effects of cytokines and inflammation?","volume":"24","author":"Harsanyi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ynstr.2025.100732_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053126","article-title":"Differential response of hippocampal subregions to stress and learning","volume":"7","author":"Hawley","year":"2012","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.ynstr.2025.100732_bib43","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"6","key":"10.1016\/j.ynstr.2025.100732_bib44","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/FBP.0000000000000394","article-title":"Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats","volume":"29","author":"Horsley","year":"2018","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ynstr.2025.100732_bib45","article-title":"Brain neurotransmitter modulation by gut microbiota in anxiety and depression","volume":"9","author":"Huang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"15","key":"10.1016\/j.ynstr.2025.100732_bib46","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1182\/blood-2011-09-336933","article-title":"Transporters in human platelets: physiologic function and impact for pharmacotherapy","volume":"119","author":"Jedlitschky","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ynstr.2025.100732_bib47","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction","volume":"28","author":"Johnson","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ynstr.2025.100732_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuropharm.2018.05.012","article-title":"The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act","volume":"142","author":"Johnson","year":"2018","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.ynstr.2025.100732_bib49","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/apt.12950","article-title":"Review article: intestinal barrier dysfunction and central nervous system disorders - a controversial association","volume":"40","author":"Julio-Pieper","year":"2014","journal-title":"Aliment Pharmacol. Therapeut."},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-81446-7","article-title":"Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing","volume":"11","author":"Kaertner","year":"2021","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.ynstr.2025.100732_bib51","first-page":"889","article-title":"Stress differentially regulates the effects of voluntary exercise on cell proliferation in the dentate gyrus of mice","volume":"19","author":"Kannangara","year":"2009","journal-title":"Hippocampus (New York, N. Y.)"},{"issue":"2","key":"10.1016\/j.ynstr.2025.100732_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijchp.2022.100349","article-title":"Seeking the psilocybiome: psychedelics meet the microbiota-gut-brain axis","volume":"23","author":"Kelly","year":"2023","journal-title":"Int. J. Clin. Health Psychol."},{"issue":"Issue 17","key":"10.1016\/j.ynstr.2025.100732_bib53","article-title":"The multifaceted role of serotonin in intestinal homeostasis","volume":"22","author":"Koopman","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ynstr.2025.100732_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mehy.2019.02.029","article-title":"Psychedelic medicine: the biology underlying the persisting psychedelic effects","volume":"125","author":"Kuypers","year":"2019","journal-title":"Med. Hypotheses"},{"issue":"5","key":"10.1016\/j.ynstr.2025.100732_bib55","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/nmo.12754","article-title":"Enteroendocrine cells: a review of their role in brain-gut communication","volume":"28","author":"Latorre","year":"2016","journal-title":"Neuro Gastroenterol. Motil."},{"issue":"5","key":"10.1016\/j.ynstr.2025.100732_bib56","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00213-020-05477-0","article-title":"Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders","volume":"237","author":"Lea","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ynstr.2025.100732_bib57","article-title":"Serum neuroactive metabolites of the tryptophan pathway in patients with acute phase of affective disorders","volume":"15","author":"Li","year":"2024","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.ynstr.2025.100732_bib58","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.9966","article-title":"Gut microbiome and depression: how microbes affect the way we think","author":"Limbana","year":"2020","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40263-021-00877-y","article-title":"Molecular mechanisms of psilocybin and implications for the treatment of depression","volume":"36","author":"Ling","year":"2022","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib60","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01732-5","article-title":"Neural networks and the anti-inflammatory effect of transcutaneous auricular vagus nerve stimulation in depression","volume":"17","author":"Liu","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"Issue 10","key":"10.1016\/j.ynstr.2025.100732_bib61","article-title":"The therapeutic potential of psilocybin","volume":"26","author":"Lowe","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ynstr.2025.100732_bib62","article-title":"A role for the serotonin 2A receptor in the expansion and functioning of human transmodal cortex","author":"Luppi","year":"2023","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.ynstr.2025.100732_bib63","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib64","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1434-3","article-title":"Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis","volume":"16","author":"Ma","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.ynstr.2025.100732_bib65","first-page":"133","article-title":"The brain-gut-microbiome Axis","volume":"6","author":"Martin","year":"2018","journal-title":"CMGH"},{"issue":"8","key":"10.1016\/j.ynstr.2025.100732_bib66","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrn3071","article-title":"Gut feelings: the emerging biology of gut-\"brain communication","volume":"12","author":"Mayer","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.ynstr.2025.100732_bib67","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"issue":"7966","key":"10.1016\/j.ynstr.2025.100732_bib68","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41586-023-06204-3","article-title":"Psychedelics reopen the social reward learning critical period","volume":"618","author":"Nardou","year":"2023","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ynstr.2025.100732_bib69","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ynstr.2025.100732_bib70","article-title":"Short chain fatty acids: microbial metabolites for gut-brain axis signalling","volume":"vol. 546","author":"O'Riordan","year":"2022"},{"issue":"4","key":"10.1016\/j.ynstr.2025.100732_bib71","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/1355621021000005937","article-title":"The pharmacology of psilocybin","volume":"7","author":"Passie","year":"2002","journal-title":"Addict. Biol."},{"key":"10.1016\/j.ynstr.2025.100732_bib72","article-title":"Utility of preclinical models in the study of psilocybin \u2013 a comprehensive review","volume":"vol. 146","author":"Pedicini","year":"2023"},{"issue":"2","key":"10.1016\/j.ynstr.2025.100732_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211023","article-title":"A systematic study of microdosing psychedelics","volume":"14","author":"Polito","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ynstr.2025.100732_bib74","first-page":"1395","article-title":"Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells","volume":"29","author":"Reigstad","year":"2015","journal-title":"FASEB (Fed. Am. Soc. Exp. Biol.) J."},{"issue":"3","key":"10.1016\/j.ynstr.2025.100732_bib75","first-page":"316","article-title":"Microdosing psychedelics as cognitive and emotional enhancers","volume":"7","author":"Rifkin","year":"2020","journal-title":"Psychol. Conscious.: Theory Res. Pract."},{"key":"10.1016\/j.ynstr.2025.100732_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.729425","article-title":"Psychedelics, sociality, and human evolution","volume":"12","author":"Rodr\u00edguez Arce","year":"2021","journal-title":"Front. Psychol."},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib77","article-title":"Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls","volume":"12","author":"Rootman","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib78","first-page":"1","article-title":"Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls","volume":"12","author":"Rootman","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01811-4","article-title":"Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers","volume":"11","author":"Rootman","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ynstr.2025.100732_bib80","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/0269881120908004","article-title":"Microdosing psychedelics: demographics, practices, and psychiatric comorbidities","volume":"34","author":"Rosenbaum","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.ynstr.2025.100732_bib81","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/0269881120908004","article-title":"Microdosing psychedelics: demographics, practices, and psychiatric comorbidities","volume":"34","author":"Rosenbaum","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ynstr.2025.100732_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.105046","article-title":"A preliminary study of gut microbiome variation and HPA axis reactivity in healthy infants","volume":"124","author":"Rosin","year":"2021","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"10.1016\/j.ynstr.2025.100732_bib83","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ynstr.2025.100732_bib84","author":"Rudzki"},{"key":"10.1016\/j.ynstr.2025.100732_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1130689","article-title":"Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis","volume":"14","author":"Rusch","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ynstr.2025.100732_bib86","author":"Schlag"},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib87","doi-asserted-by":"crossref","DOI":"10.1093\/nc\/niz003","article-title":"Psychedelics as a treatment for disorders of consciousness","volume":"2019","author":"Scott","year":"2019","journal-title":"Neurosci. Conscious."},{"issue":"5","key":"10.1016\/j.ynstr.2025.100732_bib88","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1021\/acschemneuro.6b00414","article-title":"Diverse effects of gut-derived serotonin in intestinal inflammation","volume":"8","author":"Shajib","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.ynstr.2025.100732_bib89","first-page":"483","article-title":"The healthy microbiome\u2014what is the definition of a healthy gut microbiome?","volume":"160","author":"Shanahan","year":"2021","journal-title":"Gastroenterology (New York, N. Y., 1943)"},{"issue":"16","key":"10.1016\/j.ynstr.2025.100732_bib90","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.ynstr.2025.100732_bib91","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1093\/brain\/awac256","article-title":"Understanding the effects of serotonin in the brain through its role in the gastrointestinal tract","volume":"145","author":"Shine","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.ynstr.2025.100732_bib92","doi-asserted-by":"crossref","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.ynstr.2025.100732_bib93","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/02698811211008554","article-title":"Psychedelics and health behaviour change","volume":"36","author":"Teixeira","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ynstr.2025.100732_bib94","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/164_2016_103","article-title":"Serotonergic mechanisms regulating the GI tract: experimental evidence and therapeutic relevance","volume":"239","author":"Terry","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"issue":"24","key":"10.1016\/j.ynstr.2025.100732_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21249338","article-title":"Searching for peripheral biomarkers in neurodegenerative diseases: the tryptophan-kynurenine metabolic pathway","volume":"21","author":"T\u00f6r\u00f6k","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.ynstr.2025.100732_bib96","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1503\/cmaj.141124","article-title":"Psychedelic medicine: a re-emerging therapeutic paradigm","volume":"187","author":"Tupper","year":"2015","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"key":"10.1016\/j.ynstr.2025.100732_bib97","article-title":"Inflammation and mitochondrial dysfunction: a vicious circle in neurodegenerative disorders?","volume":"710","author":"van Horssen","year":"2019"},{"issue":"6633","key":"10.1016\/j.ynstr.2025.100732_bib99","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.adf0435","article-title":"Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors","volume":"379","author":"Vargas","year":"2023","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ynstr.2025.100732_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/S0896-6273(01)00192-1","article-title":"The role of RNA editing of kainate receptors in synaptic plasticity and seizures","volume":"29","author":"Vissel","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.ynstr.2025.100732_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110145","article-title":"Gut microbiota, kynurenine pathway and mental disorders \u2013 review","volume":"106","author":"Wi\u0119d\u0142ocha","year":"2021","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"2","key":"10.1016\/j.ynstr.2025.100732_bib102","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume":"161","author":"Yano","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ynstr.2025.100732_bib103","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.108.143461","article-title":"Serotonin 5-Hydroxytryptamine2A receptor activation suppresses tumor necrosis factor-\u00ee\u00b1-induced inflammation with extraordinary potency","volume":"327","author":"Yu","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"OCT","key":"10.1016\/j.ynstr.2025.100732_bib104","article-title":"The role of serotonin 5-HT2A receptors in memory and cognition","volume":"6","author":"Zhang","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ynstr.2025.100732_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114985","article-title":"Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: a review","volume":"164","author":"Zhao","year":"2023","journal-title":"Biomed. Pharmacother."}],"container-title":["Neurobiology of Stress"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352289525000268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352289525000268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T19:30:12Z","timestamp":1748719812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352289525000268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":104,"alternative-id":["S2352289525000268"],"URL":"https:\/\/doi.org\/10.1016\/j.ynstr.2025.100732","relation":{},"ISSN":["2352-2895"],"issn-type":[{"value":"2352-2895","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Stress","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ynstr.2025.100732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100732"}}